Rosalind Advisors, Inc. - Stock Holdings in 13F Filings (SEC)
Updated on March 15, 2026.
Based on 13F Filings filed with the SEC on February 12, 2026, for the 2025 Q4 period, Rosalind Advisors, Inc. held in its portfolio 42 assets valued at $284,527,096 (i.e. $284.53M).
The most valuable assets in the portfolio included: DELCATH SYSTEMS, INC. ($33.00M), SAVARA INC ($20.52M), and FENNEC PHARMACEUTICALS INC ($20.12M).
The chart below shows the top 10 valuable assets, and the table below shows the top 42 valuable assets.
You can see similar for other investment managers.
Related Topics: SEC Topic List.
Data Source: SEC.
Rosalind Advisors, Inc. - Stock Holdings in 13F Filings (SEC)
Items per page:
25
0 of 0
| Name of Issuer | No. of Shares | Value ($) | Class |
|---|---|---|---|
| DELCATH SYSTEMS, INC. | 3300389 | 33003890 | COM NEW |
| SAVARA INC | 3403721 | 20524438 | COM |
| FENNEC PHARMACEUTICALS INC | 2613508 | 20124012 | COM |
| XERIS BIOPHARMA HOLDGS INC | 2111700 | 16576845 | COM |
| VIRIDIAN THERAPEUTICS INC | 450000 | 14004000 | COM |
| MEDIWOUND LTD | 749054 | 13827537 | SHS NEW |
| VERASTEM INC | 1788475 | 13807027 | COM NEW |
| REPLIMUNE GROUP INC | 1410497 | 13710031 | COM |
| ASTRIA THERAPEUTICS INC | 1039080 | 13601557 | COM |
| CYBIN INC | 1657540 | 13558677 | COM NEW |
| EYEPOINT PHARMACEUTICALS INC | 690000 | 12606300 | COM NEW |
| CG ONCOLOGY INC | 300000 | 12456000 | COM |
| CYTOKINETICS INC | 195045 | 12393159 | COM NEW |
| X4 PHARMACEUTICALS INC | 2605920 | 10423680 | COM NEW |
| MIND MEDICINE MINDMED INC | 750000 | 10042500 | COM NEW |
| PROFOUND MEDICAL CORP | 1068955 | 8412676 | COM NEW |
| INSPIREMD INC | 3905743 | 6952222 | COM |
| Ocular Therapeutix, Inc | 400000 | 4856000 | COM |
| ARRIVENT BIOPHARMA INC | 215871 | 4343325 | COM |
| TALPHERA INC | 3579273 | 4080371 | COM NEW |
| MYOMO INC | 3839772 | 3494193 | COM NEW |
| INVESCO QQQ TR | 450000 | 3028500 | PUT |
| POLYPID LTD | 696556 | 3023053 | COM |
| ONKURE THERAPEUTICS INC | 730488 | 2118415 | COM CL A |
| SPDR S&P 500 ETF TR | 510000 | 1886100 | PUT |
| ANAVEX LIFE SCIENCES CORP | 1168600 | 1880860 | PUT |
| REGENTIS BIOMATERIALS LTD | 251510 | 1695177 | ORDINARY SHARES |
| SPDR SERIES TRUST | 1937600 | 1347600 | PUT |
| TREVI THERAPEUTICS INC | 100000 | 1252000 | COM |
| ISHARES TR | 200000 | 1112000 | PUT |
| NEURAXIS INC | 286138 | 1039253 | COM |
| KURA ONCOLOGY INC | 100000 | 1039000 | COM |
| FRACTYL HEALTH INC | 385731 | 848608 | COM |
| BIOFRONTERA INC | 1140764 | 650235 | COM NEW |
| ARRIVENT BIOPHARMA INC | 107900 | 539500 | CALL |
| VERASTEM INC | 268600 | 159810 | CALL |
| UNIQURE NV | 100000 | 95000 | CALL |
| REPLIMUNE GROUP INC | 230900 | 11545 | CALL |
| VIKING THERAPEUTICS INC | 100000 | 2000 | CALL |
| REPLIMUNE GROUP INC | 264700 | 0 | PUT |
| REZOLUTE INC | 263100 | 0 | CALL |
| VISTAGEN THERAPEUTICS INC | 493400 | 0 | CALL |